Akoya Biosciences announced the establishment of its Scientific Advisory Board to provide strategic guidance and consult on the Company’s efforts to deliver spatial biology solutions for the life sciences industry, from discovery to diagnostics. The initial members of Akoya’s Scientific Advisory Board are: Garry Nolan, Ph.D., Rachford and Carlota Harris Professor in the Department of Pathology at Stanford University School of Medicine, co-founder of Akoya Biosciences and inventor of the CODEX technology. James Allison, Ph.D. Padmanee Sharma, M.D., Ph.D. Jeanette Hsu.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AKYA:
- Akoya Biosciences sees preliminary Q4 revenue $25.5M-$26.5M, consensus $26.3M
- Akoya Biosciences, Thermo Fisher announce license/distribution agreement
- Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
- Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
- Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
